Kyverna therapeutics to participate in upcoming september investor conferences

Emeryville, calif., aug. 21, 2024 /prnewswire/ -- kyverna therapeutics, inc. (kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today that the company's executives will participate in the following investor events: investor conference details:     morgan stanley global healthcare conference in new york, ny on september 4, 2024 format: fireside chat with mike ulz at 11:30 am edt and host investor meetings wells fargo healthcare conference in boston, ma on september 5, 2024 format: fireside chat with derek archila at 2:15 pm edt and host investor meetings cantor global healthcare conference in new york, ny on september 17, 2024 format: fireside chat with eric schmidt at 10:20 am edt and host investor meetings investors interested in scheduling a meeting with management during one of the investor conferences listed above should contact their morgan stanley, wells fargo, or cantor sales representative.
KYTX Ratings Summary
KYTX Quant Ranking